Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control

Published:2016-09-18 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Vos Rimke C¹,van Avendonk Mariëlle JP²,Jansen Hanneke¹,Goudswaard Alexander Nicolaas N³,van den Donk Maureen²,Gorter Kees⁴,Kerssen Anneloes¹,Rutten Guy EHM¹

Affiliation:

1. University Medical Center Utrecht; Julius Center for Health Sciences and Primary Care; PO Box 85500 Utrecht Netherlands 3508 AB

2. Guideline Development and Research; Dutch College of General Practitioners; PO Box 3231 Utrecht Netherlands 3502 GE

3. Koperslagersgilde 5 Houten Netherlands 3994CH

4. Utrecht Netherlands 3508 GA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference204 articles.

1. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial;Avilés-Santa;Annals of Internal Medicine,1999

2. Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy;Barnett;Clinical drug investigation,2013

3. Insulin-glyburide combination therapy for non-insulin-dependent diabetes mellitus: a long-term double-blind, placebo-controlled trial;Casner;Clinical Pharmacology and Therapeutics,1988

4. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus;Chiasson;Annals of Internal Medicine,1994

5. A double-blind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type 2 diabetes;Coniff;Diabetes Care,1995

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy of switching basal–bolus insulin therapy to basal insulin-supported oral therapy with a glinide and an α-glucosidase inhibitor in patients with type 2 diabetes depends on insulin secretory capacity, but not on blood glucose profiles and insulin dosages prior to the switching;Diabetology International;2023-09-04

2. The efficacy of switching basal-bolus insulin therapy to basal insulin-supported oral therapy with a glinide and an a-glucosidase inhibitor in patients with type 2 diabetes depends on insulin secretory capacity, but not on blood glucose profiles and insulin dosages prior to the switching;DIABETOL INT;2023

3. Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study;BMJ Open Diabetes Research & Care;2023-04

4. A pre-clinical study to investigate the anti-diabetic potential of p-propoxybenzoic acid as a multi-target inhibitor in streptozotocin-nicotinamide induced type-2 diabetic rats;Journal of Diabetes & Metabolic Disorders;2022-12-31

5. The role of Recent Pharmacotherapeutic Options on the Management of Treatment Resistant Type 2 Diabetes;Expert Opinion on Pharmacotherapy;2022-06-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3